Type | Transmission | Risk Factors | Serologies |
---|---|---|---|
Hepatitis A | Fecal-oral | Contaminated food and water Children and caregivers in daycare centers | Acute IgM anti-HAV+ Chronic N/A Recovered/latent IgG anti-HAV+ Vaccinated IgG anti-HAV+ |
Hepatitis B | Blood Percutaneous Sexual Perinatal | Intravenous drug users Unsafe sexual practices Infants born to infected mothers Health care workers Transfusion recipients | Acute HBsAg+ IgM anti-HBc+ HBeAg+ HBV DNA+ Chronic IgG anti-HBc+ HBeAg+/− (present during periods of high replication) Anti-HBe+/− (present during periods of low replication) HBsAg+ HBV DNA +/− (present during periods of high replication) Recovered/latent IgG anti-HBc+ HBV DNA-HBeAg− Anti-HBe+/− HBsAg− Anti-HBs+ Vaccinated Anti-HBs+ only |
Hepatitis C | Blood Percutaneous Sexual (rare) Perinatal (rare) | Intravenous drug users Transfusion recipients | Acute All tests possibly negative HCV RNA+ Anti-HCV Ab+ in 8-10 weeks Chronic Anti-HCV Ab+ HCV RNA+ Recovered/latent Anti-HCV Ab+ HCV RNA− Vaccinated N/A |
Hepatitis D | Blood Sexual (rare) | Any person with hepatitis B Intravenous drug users | Positive hepatitis B serologies plus the following: Acute IgM anti-HDV+ HDV Ag+ Chronic IgG anti-HDV+ Recovered/latent IgG anti-HDV+ Vaccinated N/A |
Hepatitis E | Fecal-oral | Contaminated food and water Travel to endemic regions | IgM anti-HEV through Centers for Disease Control (CDC) |
Adapted from Green GB, Harris IS, Lin GA, et al., eds. The Washington Manual of Medical Therapeutics. 31st ed. Philadelphia: Lippincott Williams & Wilkins; 2004:382, with permission. |

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

